글로벌 유방 재건 시장 - 업계 동향 및 2031년까지의 예측

유방 재건 시장 분석 및 규모

유방 재건은 유방암이나 기타 의학적 상태로 인해 유방 절제술을 받은 개인의 전반적인 치료 및 회복 과정에서 중요한 구성 요소입니다. 여성의 여성성과 신체 이미지에 대한 감각을 회복하는 데 중요한 역할을 하며 심리적, 정서적 웰빙에 긍정적인 영향을 미칩니다. 유방 재건은 유방암이나 트라우마를 경험한 여성의 삶의 질을 향상시키는 데 기여합니다. 개인이 자신감, 자존감, 그리고 삶에서 정상성을 되찾을 수 있도록 합니다.

Data Bridge Market Research는 2023년에 4억 9,210만 달러였던 글로벌 유방 재건 시장이 2031년까지 1,051.27만 달러에 도달할 가능성이 높으며 예측 기간 동안 8.8%의 CAGR을 보일 것으로 분석했습니다. 유방 수술의 유행이 증가함에 따라 " 유방 임플란트"가 유방 재건 시장의 제품 부문을 지배하고 있습니다.

Data Bridge Market Research에서 큐레이팅한 시장 보고서에는 시장 가치, 성장률, 세분화, 지리적 범위, 주요 업체와 같은 시장 시나리오에 대한 통찰력 외에도 심층적인 전문가 분석, 환자 역학, 파이프라인 분석, 가격 분석 및 규제 프레임워크가 포함되어 있습니다.

보고 범위 및 시장 세분화

시장 정의

유방 재건은 유방 절제술, 덩어리 절제술 또는 기타 외상이나 선천적 이상 후 한쪽 또는 양쪽 유방의 모양, 크기, 대칭성 및 외관을 회복하는 것을 목표로 하는 외과적 시술 또는 일련의 시술을 말합니다. 유방 재건의 주요 목표는 유방 손실의 신체적, 심리적 영향을 해결하는 동시에 자연스러운 유방 윤곽을 재현하는 것입니다. 유방 재건을 받을지 여부는 매우 개인적이며 개인의 건강, 선호도 및 상황을 포함한 다양한 요인에 따라 달라집니다. 유방암 치료를 위해 유방 절제술을 받았거나 유방암에 걸릴 위험이 높은 여성은 신체적 외관을 회복하고 전반적인 웰빙을 향상시키기 위해 유방 재건을 선택할 수 있습니다.

글로벌 유방 재건 시장 역학

운전자

• 유방암 발병률 증가

전 세계적으로 유방암 발병률이 증가하는 것은 유방 재건 시장의 중요한 원동력입니다. 더 많은 여성이 유방암 치료의 일환으로 유방 절제술을 받으면서 유방의 물리적 외관을 회복하기 위한 유방 재건 수술에 대한 수요가 증가하면서 시장 성장에 기여하고 있습니다.

• 수술 기술과 기술의 발전

더욱 정교한 임플란트, 자가 조직 재건 방법, 혁신적인 수술 도구의 개발과 같은 유방 재건을 위한 수술 기법과 기술의 지속적인 발전이 시장을 주도하고 있습니다. 환자와 외과의는 개선된 미적 감각, 감소된 합병증, 빠른 회복 시간을 제공하는 시술을 찾고 있습니다.

기회

• 미적 결과에 대한 관심 증가

There is a growing emphasis on achieving aesthetically pleasing outcomes in breast reconstruction. Patients often seek procedures that not only restore the breast but also enhance its natural appearance. Advancements in implant technologies and autologous tissue reconstruction contribute to achieving more realistic and satisfying results, creating opportunities for market growth.

Restraint/Challenge

• Limited Access to Reconstructive Procedures

Limited access to breast reconstruction procedures is a significant restraint, particularly in regions with insufficient healthcare infrastructure or disparities in access to healthcare services. Factors such as geographic location, economic conditions, and lack of specialized healthcare facilities can hinder individuals' ability to undergo reconstructive surgery after mastectomy.

Recent Developments

• In April 2023, an Israeli 3D printing company, Stratasys & CollPlant Technologies which is an American bioinks company, are collaborating to create the technology to 3D-print breast implants to aid patients in regenerating their natural breast tissue. The implants are made to replace lost biological breast tissue without triggering an immune reaction. CollPlant has successfully finished a large-animal study for its 3D bio-printed regenerative breast implants, and it intends to start a follow-up study in the second half of 2023 using commercial-size implants to support upcoming human studies
• In October 2022, The LUNA xtTM was the first micro-textured anatomical breast implant to receive CE approval under the European Medical Device Regulation. Luna xtTM is developed by GC Aesthetics, and it offers an industry-leading response to surgeon and patient needs in breast reconstruction procedures
• In August 2022, 3D-printed Scaffolds were created by Australian researchers using additive manufacturing techniques, eventually taking the place of traditional silicone breast implants. The scaffold is made of the same material as dissolvable stitches and resembles a traditional implant. The research group anticipates this technology will transform breast reconstruction and cosmetic surgery procedures

Global Breast Reconstruction Market Scope

The breast reconstruction market is segmented on the basis of product, type, shape, technology, placement, procedure, and end user. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.

Product

• Breast Implants
• Tissue Expanders
• Acellular Dermal Matrix

Type

• Unilateral Breast Reconstruction
• Bilateral

Shape

• Round Implants
• Anatomical Implants

Technology

• Inframammary
• Peri-areolar
• Trans-axillary
• Trans-umbilical

Placement

• Dual-Plane Insertion
• Subglandular Insertion
• Submuscular Insertion

Procedure

• Immediate Procedures
• Delayed Procedures
• Revision Procedures

End User

• Hospitals
• Cosmetology Clinics
• Ambulatory Surgical Centers
• Others

Global Breast Reconstruction Market Regional Analysis/Insights

The breast reconstruction market is analyzed and market size insights and trends are provided by country, product, type, shape, technology, placement, procedure, and end user as referenced above.

The countries covered in the market report are U.S., Canada, Mexico, Brazil, Argentina, rest of South America, Germany, France, Italy, U.K., Belgium, Spain, Russia, Turkey, Netherlands, Switzerland, rest of Europe, Japan, China, India, South Korea, Australia, Singapore, Malaysia, Thailand, Indonesia, Philippines, rest of Asia-Pacific, U.A.E., Saudi Arabia, Egypt, South Africa, Israel, and rest of Middle East and Africa.

North America is expected to the dominate the market due to the presence of advanced healthcare infrastructure.

Asia-Pacific is expected to be the fastest-growing region in the market due to the rising prevalence of breast cancer.

The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points like down-stream and upstream value chain analysis, technical trends and porter's five forces analysis, case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.  

Healthcare Infrastructure Growth Installed Base and New Technology Penetration

The breast reconstruction market also provides you with a detailed market analysis for every country's growth in healthcare expenditure for capital equipment, installed base of different kinds of products for the breast reconstruction market, the impact of technology using lifeline curves and changes in healthcare regulatory scenarios and their impact on the breast reconstruction market.

Competitive Landscape and Breast Reconstruction Market Share Analysis

The breast reconstruction market competitive landscape provides details by competitors. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width, and breadth, application dominance. The above data points provided are only related to the companies' focus related to the breast reconstruction market.

Some of the major players operating in the breast reconstruction market are:

• POLYTECH Health & Aesthetics GmbH (Germany)
• CEREPLAS (South Korea)
• Establishment Labs S.A (Costa Rica)
• ALLERGAN (Ireland)
• AbbVie Inc. (U.S.)
• Johnson & Johnson Services, Inc. (U.S.)
• GC Aesthetics (Ireland)
• Arion Laboratories (Canada)
• IDEAL IMPLANT INCORPORATED (미국)
• 시엔트라 주식회사(미국)
• 한스바이오메드 주식회사(한국)
• 에어엑스팬더(미국)
• PMT Corporation (미국)
• 실리메드(브라질)
• 인테그라 라이프사이언스(미국)
• DPS Technology Development Ltd(홍콩)
• 완허(중국)
• 주식회사 코켄(일본)
• 세빈(프랑스)
• 데피그래비티(영국)

SKU-36080